Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Are PSA adjustments necessary for prostate cancer screening in men taking finasteride for hair loss?

Nature Clinical Practice Urology volume 4, pages 412–413 (2007)Cite this article

boxed-textD'Amico AV and Roehrborn CG (2007) Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial. Lancet Oncol 8: 21–25

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Gormley GJ et al. (1992) The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group. N Engl J Med 327: 1185–1191

    Article  CAS  Google Scholar 

  2. Marks LS et al. (2006) The interpretation of serum prostate specific antigen in men receiving 5α-reductase inhibitors: a review and clinical recommendations. J Urol 176: 868–874

    Article  CAS  Google Scholar 

  3. Guess HA et al. (1993) Effect of finasteride on serum PSA concentration in men with benign prostatic hyperplasia. Results from the North American phase III clinical trial. Urol Clin North Am 20: 627–636

    CAS  PubMed  Google Scholar 

  4. Thompson IM et al. (2006) Effect of finasteride on the sensitivity of PSA for detecting prostate cancer. J Natl Cancer Inst 98: 1128–1133

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Tamsin Osborne, Freelance Medical Writer.

Author information

Author notes

  1. The Cleveland Clinic Foundation, Desk A100, 9500 Euclid Avenue, Cleveland, OH 44195, USA kleine@ccf.org

Authors and Affiliations

  1. EA Klein is Head of the Section of Urologic Oncology at the Glickman Urological Institute, and Professor of Surgery, Cleveland Clinic Lerner College of Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA.,

    Eric A Klein

Authors
  1. Eric A Klein
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Klein, E. Are PSA adjustments necessary for prostate cancer screening in men taking finasteride for hair loss?. Nat Rev Urol 4, 412–413 (2007). https://doi.org/10.1038/ncpuro0835

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0835

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing